These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

554 related items for PubMed ID: 16732389

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The effect of clopidogrel, aspirin and both antiplatelet drugs on platelet function in patients with peripheral arterial disease.
    Jagroop IA, Matsagas MI, Geroulakos G, Mikhailidis DP.
    Platelets; 2004 Mar; 15(2):117-25. PubMed ID: 15154604
    [Abstract] [Full Text] [Related]

  • 3. How to optimise clopidogrel therapy? Reducing the low-response incidence by aggregometry-guided therapy modification.
    Neubauer H, Lask S, Engelhardt A, Mügge A.
    Thromb Haemost; 2008 Feb; 99(2):357-62. PubMed ID: 18278186
    [Abstract] [Full Text] [Related]

  • 4. Assessment of clopidogrel non-response by the PFA-100 system using the new test cartridge INNOVANCE PFA P2Y.
    Linnemann B, Schwonberg J, Rechner AR, Mani H, Lindhoff-Last E.
    Ann Hematol; 2010 Jun; 89(6):597-605. PubMed ID: 20049442
    [Abstract] [Full Text] [Related]

  • 5. Antiplatelet and antithrombotic treatment of patients with peripheral arterial disease.
    Poredos P, Jezovnik MK.
    Int Angiol; 2010 Feb; 29(1):20-6. PubMed ID: 20224527
    [Abstract] [Full Text] [Related]

  • 6. Comparison of increased aspirin dose versus combined aspirin plus clopidogrel therapy in patients with diabetes mellitus and coronary heart disease and impaired antiplatelet response to low-dose aspirin.
    Duzenli MA, Ozdemir K, Aygul N, Soylu A, Tokac M.
    Am J Cardiol; 2008 Aug 15; 102(4):396-400. PubMed ID: 18678294
    [Abstract] [Full Text] [Related]

  • 7. Response to aspirin and clopidogrel monitored with different platelet function methods.
    Mani H, Linnemann B, Luxembourg B, Kirchmayr K, Lindhoff-Last E.
    Platelets; 2006 Aug 15; 17(5):303-10. PubMed ID: 16928602
    [Abstract] [Full Text] [Related]

  • 8. [Diagnosis, causes, relevance of a complex phenomenon. Resistance to aspirin and clopidogrel].
    Mani H, Lindhoff-Last E.
    Pharm Unserer Zeit; 2009 Aug 15; 38(4):342-50. PubMed ID: 19572355
    [No Abstract] [Full Text] [Related]

  • 9. Antiplatelet effect of clopidogrel in patients with aspirin therapy undergoing percutaneous coronary interventions--limited inhibition of the P2Y12 receptor.
    Lepäntalo A, Virtanen KS, Reséndiz JC, Mikkelsson J, Viiri LE, Karhunen PJ, Lassila R.
    Thromb Res; 2009 Jun 15; 124(2):193-8. PubMed ID: 19232433
    [Abstract] [Full Text] [Related]

  • 10. The additive antiplatelet action of clopidogrel in patients with coronary artery disease treated with aspirin.
    Dropinski J, Jakiela B, Sanak M, Wegrzyn W, Biernat M, Dziedzina S, Plutecka H, Szczeklik A.
    Thromb Haemost; 2007 Jul 15; 98(1):201-9. PubMed ID: 17598014
    [Abstract] [Full Text] [Related]

  • 11. Prevalence and risk factors for aspirin and clopidogrel resistance in patients with coronary artery disease or ischemic cerebrovascular disease.
    Kim H, Lee HK, Han K, Jeon HK.
    Ann Clin Lab Sci; 2009 Jul 15; 39(3):289-94. PubMed ID: 19667414
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Relationships between optical aggregometry (type born) and flow cytometry in evaluating ADP-induced platelet activation.
    Sbrana S, Della Pina F, Rizza A, Buffa M, De Filippis R, Gianetti J, Clerico A.
    Cytometry B Clin Cytom; 2008 Jan 15; 74(1):30-9. PubMed ID: 17630652
    [Abstract] [Full Text] [Related]

  • 14. Measurement of platelet P-selectin for remote testing of platelet function during treatment with clopidogrel and/or aspirin.
    Fox SC, May JA, Shah A, Neubert U, Heptinstall S.
    Platelets; 2009 Jun 15; 20(4):250-9. PubMed ID: 19440925
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Aspirin and clopidogrel resistance: an emerging clinical entity.
    Wang TH, Bhatt DL, Topol EJ.
    Eur Heart J; 2006 Mar 15; 27(6):647-54. PubMed ID: 16364973
    [Abstract] [Full Text] [Related]

  • 18. Combination antiplatelet therapy in patients with peripheral arterial disease: is the best therapy aspirin, clopidogrel, or both?
    Mohler ER.
    Catheter Cardiovasc Interv; 2009 Jul 01; 74 Suppl 1():S1-6. PubMed ID: 19213065
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trial.
    Bhatt DL, Flather MD, Hacke W, Berger PB, Black HR, Boden WE, Cacoub P, Cohen EA, Creager MA, Easton JD, Hamm CW, Hankey GJ, Johnston SC, Mak KH, Mas JL, Montalescot G, Pearson TA, Steg PG, Steinhubl SR, Weber MA, Fabry-Ribaudo L, Hu T, Topol EJ, Fox KA, CHARISMA Investigators.
    J Am Coll Cardiol; 2007 May 15; 49(19):1982-8. PubMed ID: 17498584
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.